A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of JNJ-77242113 after single ascending oral dose administration as an immediate-release (IR) tablet formulation in healthy Japanese participants and after single oral dose administration as an IR tablet formulation in healthy Chinese participants; and as a delayed release (DR) tablet formulation in healthy Japanese participants.
Epistemonikos ID: f23923bec993fadf8b60a40a2e6acf3e41064812
First added on: May 09, 2024